Welcome to the InfoSci Platform
Biopharma Drugs Innovation in India and Foreign Investment and Technology Transfer in the Changed Patent Regime

Biopharma Drugs Innovation in India and Foreign Investment and Technology Transfer in the Changed Patent Regime

Rakhi Rashmi
Copyright: © 2013 |Pages: 14
ISBN13: 9781466621367|ISBN10: 1466621362|EISBN13: 9781466621374
DOI: 10.4018/978-1-4666-2136-7.ch040
Cite Chapter Cite Chapter

MLA

Rashmi, Rakhi. "Biopharma Drugs Innovation in India and Foreign Investment and Technology Transfer in the Changed Patent Regime." Digital Rights Management: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, IGI Global, 2013, pp. 846-859. https://doi.org/10.4018/978-1-4666-2136-7.ch040

APA

Rashmi, R. (2013). Biopharma Drugs Innovation in India and Foreign Investment and Technology Transfer in the Changed Patent Regime. In I. Management Association (Ed.), Digital Rights Management: Concepts, Methodologies, Tools, and Applications (pp. 846-859). IGI Global. https://doi.org/10.4018/978-1-4666-2136-7.ch040

Chicago

Rashmi, Rakhi. "Biopharma Drugs Innovation in India and Foreign Investment and Technology Transfer in the Changed Patent Regime." In Digital Rights Management: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, 846-859. Hershey, PA: IGI Global, 2013. https://doi.org/10.4018/978-1-4666-2136-7.ch040

Export Reference

Mendeley
Favorite

Abstract

This chapter addresses the relationship between the intellectual property rights and Foreign Direct Investment in the context of Indian biopharma Industry to assess the impact of the TRIPs agreement of WTO on the biopharmaceutical industry of developing countries. The central issue in this study is the extent to which patent reform (after the imposition of the TRIPs agreement in 1995) affects India’s ability to attract technology transfer for biopharmaceutical drugs innovation. The study analyzes FDI flow in the biopharma industry in Pre TRIPs (before the imposition of product patent protection 1991-1999) and post TRIPs (after product patent protection, 1999-2005). It does a comparative analysis of the relationship between the amount of foreign investment in different Indian states and the investment climate ranking of those states that are the part of Indian bio cluster.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.